BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 11.08.2009

Review of Post-Inspection Responses

The Food and Drug Administration (FDA) is announcing a program to support public health protection by facilitating the timely issuance of warning letters. The program establishes a timeframe for the submission and agency review of post-inspection responses to inspectional observations that are communicated to a firm through issuance of a form FDA 483, list of inspectional observations.

Source: Federal Register — Food and Drug AdministrationOpen original release →